A patient signs up for a six-month weight-loss program at $399 per month. The $399 payment covers telehealth access, clinical services, and medication coordination.
Three months later, the patient cancels their program.
If a patient cancels a weight-loss program, should they be refunded for the most recent payment? If the appointment is already held? Is the medication already prescribed? Does the pharmacy charge the patient for the medication separately? When should billing for these weight-loss programs end?
These questions make GLP-1 medication payment processing more complicated than ordinary subscription services. Your weight-loss program needs a merchant account that is able to handle these treatment-related variables.
The terminology used for medications also poses a challenge for weight-loss programs. Ozempic is the FDA-approved medication for type 2 diabetes. Wegovy is the FDA-approved medication for weight management. Each medication has specific indications for use. Using the term Ozempic to describe any weight-loss program creates confusion about the medication’s use, so each clinic should clearly describe the medication and its indication for use.
A Cancellation Can Affect Several Different Payments
The first mistake is treating the patient’s program as one indivisible subscription.
A telemedicine program may actually contain several transactions or obligations:
| What the Patient Paid For | What Cancellation May Affect |
|---|---|
| Completed telehealth consultation | Usually already delivered; review disclosed refund terms |
| Current month’s membership access | Depends on cancellation date and program terms |
| Future recurring membership fees | Stop according to the cancellation request and agreement |
| Medication not yet ordered | May still be preventable through the appropriate clinical/pharmacy workflow |
| Medication already dispensed or shipped | Requires separate review of pharmacy and refund rules |
| Separate pharmacy transaction | May belong to a different merchant of record |
| Future appointment | Cancel or reschedule through the clinical workflow |
| Unused future program months | Do not continue automatic billing after valid cancellation |
The billing team should start by identifying what has actually happened.
For example, suppose the clinic charged $399 on August 1. The patient completed a telehealth visit on August 5 and canceled on August 12. That situation differs from a patient who cancels before receiving any August services.
A cancellation of future recurring billing also does not automatically answer whether a previous transaction must be refunded. That depends on what was provided, the agreed terms and applicable law.
Separate Payment Cancellation From Clinical Decisions
The staff who handle payments should not decide whether the patient should end their prescription.
If the patient has already been prescribed, ordered, or received medication from the clinic, the clinic’s doctors and pharmacies will make that decision about the prescription. The billing software only logs the prescription and does not allow billing for it.
This is especially true if the pharmacy is the business that has the merchant of record for the patient’s pharmacy.
If the pharmacy charged the patient’s card directly for the medications, the telemedicine clinic cannot reverse that transaction. However, they can explain which company charged which portion of the patient’s medication program.
What the Payment Team Should Do When the Patient Cancels
A consistent cancellation workflow can prevent many subscription cancellation chargebacks before they reach the processor.
Start with six actions.
1. Record the Cancellation Time and Method
Document when the patient requested cancellation and how the request arrived.
Keep the:
- date and time
- patient account
- subscription or plan
- cancellation channel
- effective cancellation date
- employee or system that processed it
- confirmation sent to the patient
This timestamp becomes particularly important when a recurring transaction occurs near the cancellation date.
2. Stop Future Recurring Charges
Visa’s current rules require recurring merchants to provide a simple cancellation procedure. When the customer’s original order was accepted online, the merchant must provide at least an online cancellation procedure.
Once the patient’s authority for future recurring billing ends, the billing system should reflect it promptly.
Do not rely on staff to remember to delete a card from a spreadsheet before next month’s billing batch.
3. Determine What Has Already Been Delivered
Separate fulfilled services from future services.
Useful records can include:
- appointment date
- appointment completion
- patient portal access
- clinician documentation
- program start date
- medication-order status
- pharmacy fulfillment status
- shipment confirmation
- prior invoices
- prior refunds
For telemedicine merchant account disputes, documentation showing that a scheduled service actually occurred can be particularly valuable. Payment Nerds recommends connecting telemedicine transactions with appointment timestamps, confirmations and other proof of fulfillment.
4. Review the Refund Policy
The patient should not have to guess whether cancellation stops billing immediately, at the end of the current paid period or at another clearly disclosed point.
Refund terms should distinguish among:
- program fees
- completed consultations
- future consultations
- membership access
- pharmacy charges
- medication costs
- shipping
- deposits or prepaid program balances
Bundling everything into a single unexplained “medical weight loss” charge makes later disputes much harder to untangle.
5. Coordinate With the Pharmacy When Necessary
If fulfillment has not occurred, the appropriate pharmacy or clinical team may be able to stop an order.
If medication has already been dispensed or shipped, do not automatically promise that it can be returned or refunded. Prescription-drug rules, pharmacy policies and the merchant-of-record arrangement can affect the outcome.
FDA also continues to distinguish FDA-approved GLP-1 drugs from unapproved compounded versions. The agency says compounded drugs do not undergo FDA premarket review for safety, effectiveness and quality and recommends their use only when a patient’s medical needs cannot be met by an FDA-approved drug.
6. Send a Written Cancellation Confirmation
Tell the patient:
- that the cancellation was received
- the effective date
- whether another recurring payment will occur
- whether current access remains active
- which refund requests are being processed
- whether pharmacy charges are separate
- who to contact with billing questions
A short confirmation can prevent a patient from interpreting an expected final charge as unauthorized.
Why Mid-Program Cancellations Become Chargebacks
Visa has a specific dispute category for Canceled Recurring Transaction.
It applies when a cardholder withdraws permission for recurring billing and the merchant later processes a transaction that the cardholder says was no longer authorized.
Visa’s current rules also describe circumstances in which a merchant may respond with evidence—for example, when the cardholder requested cancellation for a different effective date, received services through that date or continued using the service after withdrawing permission to bill.
That makes the cancellation timeline critical.
Imagine:
August 10: Patient requests cancellation
August 10: Clinic confirms cancellation effective immediately
September 1: Billing system charges another $399
The clinic has created a difficult dispute.
Now consider:
August 10: Patient requests cancellation
August 10: Clinic explains that the paid membership remains active through August 31 and confirms no September renewal
August 20: Patient attends an included appointment
September 1: No new charge occurs
That creates a much clearer record.
Federal Subscription Rules Are Changing, but Clear Cancellation Practices Still Matter
Businesses should be careful with outdated references to the FTC’s 2024 “click-to-cancel” rule.
That amended rule was vacated by a federal court. In 2026, the FTC opened a new rulemaking process to consider changes to negative-option regulation. The FTC says it continues to address recurring-payment practices through existing authorities, including the FTC Act, the Restore Online Shoppers’ Confidence Act and the Telemarketing Sales Rule.
State subscription and automatic-renewal laws may add separate requirements.
For payment purposes, the practical approach remains straightforward: explain recurring terms clearly, preserve consent and make cancellation easy to find and document.
Visa’s own recurring-payment requirements apply separately from FTC rulemaking.
How Cancellation Chargebacks Can Affect VAMP
Repeated billing disputes can eventually affect more than individual refunds.
The Visa Acquirer Monitoring Program (VAMP) combines card-not-present Visa fraud and disputes into a count-based ratio:
TC40 fraud reports + TC15 disputes ÷ TC05 settled Visa transactions
For merchants in the U.S., the current Excessive Merchant threshold is 150 basis points (1.5%) and requires at least 1,500 monthly fraud reports and disputes under Visa’s published criteria. The threshold decreased from 220 to 150 basis points on April 1, 2026.
Most individual clinics will never reach that minimum count. That does not mean that smaller GLP-1 payment-processing programs can ignore cancellations.
Processors can review merchants before formal VAMP identification when they see recurring complaints, refund spikes, unusual growth or increasing disputes.
GLP-1 Billing Mistakes to Avoid
Common problems include:
- continuing billing after a valid cancellation
- failing to record when cancellation occurred
- hiding cancellation behind a phone-only process after online signup
- using one vague charge for consultations, membership and medication
- failing to identify the pharmacy as a separate merchant
- promising medication refunds before checking fulfillment status
- making the payment team responsible for clinical discontinuation decisions
- keeping recurring cards active after the program ends
- failing to disclose when the next payment will occur
- using confusing billing descriptors
- losing proof that a telehealth appointment occurred
- failing to document patient use after a cancellation request
- marketing an unapproved GLP-1 product as though it were an FDA-approved brand
- treating every chargeback as fraud
- watching refunds but not VAMP and dispute trends
The best weight loss program merchant account workflow makes it possible to reconstruct what the patient purchased, what was delivered and exactly when permission for future billing ended.
Payment Nerds works with eligible healthcare and telemedicine businesses, but it does not support peptide merchants. Medication-centered GLP-1 businesses should therefore confirm processor eligibility for their exact model rather than assuming general telemedicine approval covers the products they sell.
GLP-1 Subscription Cancellation and Payment Questions
Q: What happens to recurring payments when a patient cancels a GLP-1 program?
A: Future recurring billing should stop according to the patient’s cancellation request and the agreed cancellation terms. The clinic should document the effective date and confirm whether any current paid period remains active.
Q: Does a clinic have to refund the last monthly payment?
A: Not automatically in every situation. The answer depends on what services were already provided, the disclosed refund agreement and applicable consumer or state law.
Q: What if the patient already had a telehealth appointment?
A: Keep evidence showing the appointment occurred and what services were provided. That can help distinguish an already completed service from future program access that was cancelled.
Q: What if the medication already shipped?
A: The clinic should determine which pharmacy or merchant processed the medication transaction and follow the applicable fulfillment and refund policies. Billing personnel should not make clinical decisions about whether the medication itself should be stopped.
Q: What causes subscription cancellation chargebacks?
A: Subscription cancellation chargebacks commonly occur when billing continues after a customer believes they cancelled, the cancellation date is unclear or the merchant cannot prove what services were provided before cancellation.
Q: What should GLP-1 payment processing include?
A: A strong setup should support recurring billing consent, stored credentials, clear descriptors, cancellation tracking, refunds, patient payment records and chargeback monitoring.
Q: Why can telemedicine merchant accounts receive extra scrutiny?
A: Telemedicine commonly involves remote card-not-present transactions, recurring billing and intangible services. Those characteristics can make documentation, refund practices and predictable billing especially important to processors.
Q: Does a cancelled recurring payment affect VAMP?
A: A qualifying Visa dispute can contribute to VAMP calculations. Clinics should monitor cancellation-related disputes even when their transaction volume is far below Visa’s formal Excessive Merchant minimum.
Q: Is Ozempic approved specifically for weight loss?
A: No. Ozempic is FDA-approved for type 2 diabetes and certain related cardiovascular and kidney indications. Wegovy is the semaglutide product approved for chronic weight management in eligible patients.
What Happens to Existing and Future Payments After Cancellation?
A patient cancelling a GLP-1 program does not automatically undo every transaction that occurred before the cancellation. The payment team first needs to determine which consultations, membership periods and other services were already delivered and which future charges need to stop.
The safest recurring-payment workflow records consent, makes cancellation straightforward and connects every payment with the service or fulfillment it represents. That gives patients clearer billing and gives the merchant better evidence when a mid-program cancellation threatens to become a chargeback.
Sources
- Visa. “Visa Core Rules and Visa Product and Service Rules.” Accessed August 2026.
- Visa. “Visa Acquirer Monitoring Program Overview.” Accessed August 2026.
- Federal Trade Commission. “FTC Seeks Public Comment Regarding Negative Option Marketing Practices.” Accessed August 2026.
- Federal Trade Commission. “Negative Option Rule.” Accessed August 2026.
- U.S. Food and Drug Administration. “FDA’s Concerns With Unapproved GLP-1 Drugs Used for Weight Loss.” Accessed August 2026.
- U.S. Food and Drug Administration. “FDA-Approved GLP-1 Receptor Agonists.” Accessed August 2026.
